UBS Group’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Buy |
382,482
+257
| +0.1% | +$319 | ﹤0.01% | 4885 |
|
|
2025
Q1 | $466K | Sell |
382,225
-33,130
| -8% | -$40.4K | ﹤0.01% | 4725 |
|
|
2024
Q4 | $748K | Buy |
415,355
+399,108
| +2,457% | +$718K | ﹤0.01% | 4430 |
|
|
2024
Q3 | $82.7K | Buy |
16,247
+14,029
| +633% | +$71.4K | ﹤0.01% | 5294 |
|
|
2024
Q2 | $15.8K | Sell |
2,218
-3,707
| -63% | -$26.4K | ﹤0.01% | 6306 |
|
|
2024
Q1 | $16.2K | Buy |
+5,925
| New | +$16.2K | ﹤0.01% | 5842 |
|
|
2023
Q4 | – | Sell |
-89
| Closed | -$234 | – | 8662 |
|
|
2023
Q3 | $234 | Buy |
+89
| New | +$234 | ﹤0.01% | 7519 |
|
|
2022
Q3 | – | Sell |
-2,282
| Closed | -$7K | – | 9792 |
|
|
2022
Q2 | $7K | Buy |
2,282
+666
| +41% | +$2.04K | ﹤0.01% | 7506 |
|
|
2022
Q1 | $14K | Sell |
1,616
-2,822
| -64% | -$24.4K | ﹤0.01% | 6921 |
|
|
2021
Q4 | $47K | Sell |
4,438
-9,435
| -68% | -$99.9K | ﹤0.01% | 5872 |
|
|
2021
Q3 | $249K | Buy |
+13,873
| New | +$249K | ﹤0.01% | 4139 |
|